Cyclophosphamide and Prednisone in Nephrosis
نویسندگان
چکیده
منابع مشابه
Paired trial of cyclophosphamide and prednisone in children with nephrosis.
Tsao, Y. C., and Yeung, C. H. (1971). Archives of Disease in Childhood, 46, 327. Paired trial of cyclophosphamide and prednisone in children with nephrosis. Cyclophosphamide and prednisone were compared as the primary treatment for the nephrotic syndrome in 27 boys and 4 girls. The patients, aged between 2j and 11, were paired according to their renal histology; 19 belonged to the minimal chang...
متن کاملPulmonary complications of combination therapy with cyclophosphamide and prednisone.
Oral cyclophosphamide and prednisone are standard treatment for some neoplasms and necrotizing systemic vasculitis and are advocated with increasing frequency for idiopathic interstitial lung disease. During a 15-month period, we observed four cases of acute respiratory failure from Pneumocystis carinii pneumonia (PCP) in patients treated with oral cyclophosphamide and prednisone. One patient e...
متن کاملTreatment of hemophagocytic lymphohistiocytosis with cyclophosphamide, vincristine, and prednisone.
The goal of this study was to observe the therapeutic efficacy of cyclophosphamide, vincristine and prednisone combined chemotherapy (COP) in treating adult haemophagocytic lymphohistiocytosis (HLH). Fifteen cases diagnosed with HLH were enrolled in our study. Each of them was treated with the COP regimen. Two of the fifteen patients had autoimmune disease-associated HLH (13.3%), 2/15 had lymph...
متن کاملSuccessful Treatment of TAFRO Syndrome with Tocilizumab, Prednisone, and Cyclophosphamide
TAFRO syndrome is a rare systemic inflammatory disease characterized by thrombocytopenia, pleural effusion, fever, renal dysfunction, reticulin fibrosis of the bone marrow, and organomegaly. The clinical course varies significantly among patients. However, the prognosis is usually dismal in patients with severe TAFRO syndrome, and no optimal treatment has yet been established. We herein describ...
متن کاملA cooperative study of epirubicin with cyclophosphamide, vincristine and prednisone (CEOP) in non-Hodgkin's lymphoma.
BACKGROUND The purpose of our cooperative trial was to investigate whether epirubicin (EPI) at 90 mg/m2 in a CHOP-like combination (called CEOP) could increase complete response (CR) and survival rates in non-Hodgkin lymphoma (NHL) patients while maintaining a tolerable degree of toxicity. METHODS Between September 1986 and July 1992, 218 patients from 12 Centers in Lombardy entered this stud...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Archives of Disease in Childhood
سال: 1971
ISSN: 0003-9888,1468-2044
DOI: 10.1136/adc.46.248.575